|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 901 New York Ave NW |
Address2 | Suite 515E |
City | Washington |
State | DC |
Zip Code | 20001-4432 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1967-12
|
||||||||
|
6. House ID# 317210000
|
TYPE OF REPORT | 8. Year | 2021 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lupe Gonzales Jr |
Date | 6/12/2021 1:57:23 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Opioids, pain management
Federal funding for Substance Use Disorder treatments
H.R.1384-Mainstreaming Addiction Treatment Act of 2021
S.445-Mainstreaming Addiction Treatment Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Associate Executive Director, Public Affairs & Wash DC Office |
|
Brad |
Gruehn |
|
Congressional Affairs Director |
|
Ryan |
McBride |
|
Senior Congressional Lobbyist |
|
Jeanne |
Slade |
|
Director, NEMPAC & ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Federal funding to implement Alternatives to Opioids (ALTO) program
Federal funding to implement Preventing Overdoses While in Emergency Rooms (POWER) program
Federal funding to implement MISSION ZERO program
Federal funding to implement firearm injury prevention
Federal funding to implement Emergency Medical Services for Children (EMSC)
Federal funding for emergency medicine research activities
H.Con.Res.11-Establishing the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030
S.Con.Res.5-A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030
H.R.315-Medicare Sequester COVID Moratorium Act
H.R.1868-To prevent across-the-board direct spending cuts, and for other purposes
P.L.117-2-American Rescue Plan Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Associate Executive Director, Public Affairs & Wash DC Office |
|
Brad |
Gruehn |
|
Congressional Affairs Director |
|
Ryan |
McBride |
|
Senior Congressional Lobbyist |
|
Jeanne |
Slade |
|
Director, NEMPAC & ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
H.R.1195-Workplace Violence Prevention for Health Care and Social Service Workers Act
H.R.1260-Bipartisan Solution to Cyclical Violence Act of 2021
H.R.1620-Violence Against Women Act Reauthorization Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Associate Executive Director, Public Affairs & Wash DC Office |
|
Brad |
Gruehn |
|
Congressional Affairs Director |
|
Ryan |
McBride |
|
Senior Congressional Lobbyist |
|
Jeanne |
Slade |
|
Director, NEMPAC & ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DIS
16. Specific lobbying issues
Access to emergency medical supplies (including Personal Protective Equipment, COVID-19 tests, ventilators, and medications) during COVID-19 public health emergency
H.R.1306-National Coronavirus Commission Act of 2021
S.412-National Coronavirus Commission Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Associate Executive Director, Public Affairs & Wash DC Office |
|
Brad |
Gruehn |
|
Congressional Affairs Director |
|
Ryan |
McBride |
|
Senior Congressional Lobbyist |
|
Jeanne |
Slade |
|
Director, NEMPAC & ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
H.R.8-Bipartisan Background Checks Act of 2021
H.R.1446-Enhanced Background Checks Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Associate Executive Director, Public Affairs & Wash DC Office |
|
Brad |
Gruehn |
|
Congressional Affairs Director |
|
Ryan |
McBride |
|
Senior Congressional Lobbyist |
|
Jeanne |
Slade |
|
Director, NEMPAC & ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R.1195-Workplace Violence Prevention for Health Care and Social Service Workers Act
H.R.1205-Improving Mental Health Access from the Emergency Department Act of 2021
H.R.1260-Bipartisan Solution to Cyclical Violence Act of 2021
H.R.1324-Effective Suicide Screening and Assessment in the Emergency Department Act of 2021
H.R.1384-Mainstreaming Addiction Treatment Act of 2021
H.R.1620-Violence Against Women Act Reauthorization Act of 2021
H.R.1667-To address behavioral health and well-being among health care professionals
S.445-Mainstreaming Addiction Treatment Act of 2021
S.610-Dr. Lorna Breen Health Care Provider Protection Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Associate Executive Director, Public Affairs & Wash DC Office |
|
Brad |
Gruehn |
|
Congressional Affairs Director |
|
Ryan |
McBride |
|
Senior Congressional Lobbyist |
|
Jeanne |
Slade |
|
Director, NEMPAC & ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
H.R.1364-Parity Enforcement Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Associate Executive Director, Public Affairs & Wash DC Office |
|
Brad |
Gruehn |
|
Congressional Affairs Director |
|
Ryan |
McBride |
|
Senior Congressional Lobbyist |
|
Jeanne |
Slade |
|
Director, NEMPAC & ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
H.R.1195-Workplace Violence Prevention for Health Care and Social Service Workers Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Associate Executive Director, Public Affairs & Wash DC Office |
|
Brad |
Gruehn |
|
Congressional Affairs Director |
|
Ryan |
McBride |
|
Senior Congressional Lobbyist |
|
Jeanne |
Slade |
|
Director, NEMPAC & ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Federal funding for emergency medicine research activities
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Associate Executive Director, Public Affairs & Wash DC Office |
|
Brad |
Gruehn |
|
Congressional Affairs Director |
|
Ryan |
McBride |
|
Senior Congressional Lobbyist |
|
Jeanne |
Slade |
|
Director, NEMPAC & ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R.315-Medicare Sequester COVID Moratorium Act
H.R.1868-To prevent across-the-board direct spending cuts, and for other purposes
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Associate Executive Director, Public Affairs & Wash DC Office |
|
Brad |
Gruehn |
|
Congressional Affairs Director |
|
Ryan |
McBride |
|
Senior Congressional Lobbyist |
|
Jeanne |
Slade |
|
Director, NEMPAC & ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | 901 New York Ave NW, Suite 515E |
||||||
City | Washington DC |
State | DC |
Zip Code | 20001-4432 |
Country | USA |
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |